CA3140043A1 - Compositions comprising ephedrine or an ephedrine salt and methods of making and using same - Google Patents

Compositions comprising ephedrine or an ephedrine salt and methods of making and using same Download PDF

Info

Publication number
CA3140043A1
CA3140043A1 CA3140043A CA3140043A CA3140043A1 CA 3140043 A1 CA3140043 A1 CA 3140043A1 CA 3140043 A CA3140043 A CA 3140043A CA 3140043 A CA3140043 A CA 3140043A CA 3140043 A1 CA3140043 A1 CA 3140043A1
Authority
CA
Canada
Prior art keywords
months
ephedrine
composition
sulfate
ready
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3140043A
Other languages
English (en)
French (fr)
Inventor
Shahid Ahmed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nexus Pharmaceuticals Inc
Original Assignee
Nexus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=73230956&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA3140043(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nexus Pharmaceuticals Inc filed Critical Nexus Pharmaceuticals Inc
Publication of CA3140043A1 publication Critical patent/CA3140043A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3140043A 2019-05-16 2020-05-16 Compositions comprising ephedrine or an ephedrine salt and methods of making and using same Pending CA3140043A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962849125P 2019-05-16 2019-05-16
US62/849,125 2019-05-16
PCT/US2020/033310 WO2020232424A1 (en) 2019-05-16 2020-05-16 Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Publications (1)

Publication Number Publication Date
CA3140043A1 true CA3140043A1 (en) 2020-11-19

Family

ID=73230956

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3140043A Pending CA3140043A1 (en) 2019-05-16 2020-05-16 Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Country Status (10)

Country Link
US (7) US11090278B2 (https=)
EP (1) EP3968975A4 (https=)
JP (3) JP2022532657A (https=)
KR (2) KR20240096847A (https=)
CN (1) CN113825500A (https=)
AU (1) AU2020276619A1 (https=)
CA (1) CA3140043A1 (https=)
IL (1) IL288044A (https=)
MX (1) MX2021013888A (https=)
WO (1) WO2020232424A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022532657A (ja) 2019-05-16 2022-07-15 ネクサス ファーマシューティカルズ， インコーポレイテッド エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法
US10869845B1 (en) 2020-01-22 2020-12-22 Nevakar Inc. Ephedrine compositions and methods
US20230172840A1 (en) * 2021-12-05 2023-06-08 Fresenius Kabi Austria Gmbh Ephedrine liquid formulations
CN120241601B (zh) * 2025-06-04 2025-08-22 成都苑东生物制药股份有限公司 盐酸麻黄碱注射液及其制剂工艺

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK339289D0 (da) 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
US7149574B2 (en) * 2003-06-09 2006-12-12 Palo Alto Investors Treatment of conditions through electrical modulation of the autonomic nervous system
FR2890316B1 (fr) 2005-09-02 2007-10-05 Aguettant Soc Par Actions Simp Seringue destinee a etre remplie puis sterilisee par autoclavage a la vapeur.
FR2896168B1 (fr) 2006-01-19 2008-10-17 Aguettant Soc Par Actions Simp Seringue hypodermique preremplie equipee d'un dispositif de bouchage
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
KR101906132B1 (ko) * 2010-07-17 2018-10-10 메르크 파텐트 게엠베하 침투 및 작용의 증진
FR2963237B1 (fr) 2010-07-28 2013-05-17 Aguettant Lab Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain
CA2828635C (en) * 2011-03-04 2020-01-14 Grunenthal Gmbh Parenteral administration of tapentadol
FR2992222B1 (fr) 2012-06-22 2015-06-19 Aguettant Lab Dispositif de protection destine a equiper un dispositif d’injection pourvu d’un embout de raccordement
US10092701B2 (en) * 2014-05-19 2018-10-09 Medicom Innovation Partner A/S Medical cartridge comprising a one way valve
ES2770731T3 (es) * 2014-08-28 2020-07-02 Sun Pharmaceutical Ind Ltd Forma de dosificación parenteral de norepinefrina
FR3053893B1 (fr) 2016-07-13 2018-07-27 Laboratoire Aguettant Dispositif medical comportant un emballage et une seringue pre-remplie disposee dans l’emballage
CA3051467C (en) * 2017-01-30 2022-11-29 Nevakar, Inc Norepinephrine compositions and methods therefor
WO2019177725A1 (en) 2018-03-13 2019-09-19 Nevakar Inc. Prefilled syringe, compositions and methods
FR3084263B1 (fr) 2018-07-27 2020-07-10 Laboratoire Aguettant Systeme d’administration comportant un dispositif d’administration et un dispositif de protection pourvu d’une membrane de fermeture
JP2022532657A (ja) 2019-05-16 2022-07-15 ネクサス ファーマシューティカルズ， インコーポレイテッド エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法
US10869845B1 (en) 2020-01-22 2020-12-22 Nevakar Inc. Ephedrine compositions and methods

Also Published As

Publication number Publication date
KR20240096847A (ko) 2024-06-26
US11464752B2 (en) 2022-10-11
US20210353561A1 (en) 2021-11-18
US20210393552A1 (en) 2021-12-23
US11090278B2 (en) 2021-08-17
AU2020276619A1 (en) 2021-12-16
US11241400B2 (en) 2022-02-08
US11478436B2 (en) 2022-10-25
CN113825500A (zh) 2021-12-21
JP2025071269A (ja) 2025-05-02
WO2020232424A1 (en) 2020-11-19
US20200360309A1 (en) 2020-11-19
US20220265580A2 (en) 2022-08-25
US20230068187A1 (en) 2023-03-02
EP3968975A4 (en) 2023-02-15
JP2022532657A (ja) 2022-07-15
KR20220009985A (ko) 2022-01-25
EP3968975A1 (en) 2022-03-23
JP2023091072A (ja) 2023-06-29
US20220257539A1 (en) 2022-08-18
US11426369B2 (en) 2022-08-30
MX2021013888A (es) 2022-01-24
KR102675027B1 (ko) 2024-06-14
US20230025407A1 (en) 2023-01-26
US20220110892A1 (en) 2022-04-14
US11571398B1 (en) 2023-02-07
IL288044A (en) 2022-01-01

Similar Documents

Publication Publication Date Title
US11478436B2 (en) Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
KR101632103B1 (ko) 덱스메데토미딘 프레믹스 제형
KR102762473B1 (ko) 안정한 ast-3424 주사액 제제 및 이의 제조 방법
DK2579875T3 (en) Compositions comprising buprenorphine
US11964020B2 (en) Method for removing acetaldehyde
US11819497B2 (en) Liquid nimodipine compositions
WO2021216450A1 (en) Opioid antagonist formulations
HK40068558A (en) Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
US12295932B2 (en) Succinylcholine chloride prefilled syringe
CN104688675B (zh) 一种盐酸利多卡因注射液的制备方法
JPH10287569A (ja) アシクロビル又はその塩の輸液型キット注射剤
EP4456898A1 (en) Hydralazine compositions and methods
CN121175032A (zh) 一种注射液制剂、配伍药液及其制备方法

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220927

C11 Application revival requested

Free format text: ST27 STATUS EVENT CODE: N-6-6-C10-C11-C106 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REINSTATEMENT REQUEST RECEIVED

Effective date: 20240920

R00 Party data change recorded

Free format text: ST27 STATUS EVENT CODE: N-6-6-R10-R00-R113 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CHANGE OF ADDRESS OR METHOD OF CORRESPONDENCE REQUEST RECEIVED

Effective date: 20240920

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20241018

C11 Application revival requested

Free format text: ST27 STATUS EVENT CODE: N-6-6-C10-C11-C106 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REINSTATEMENT REQUEST RECEIVED

Effective date: 20241118

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250129

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: N-6-6-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250512

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: N-6-6-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250512

C13 Application revived following an application revival request

Free format text: ST27 STATUS EVENT CODE: A-6-2-C10-C13-C102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REINSTATEMENT REQUIREMENTS DEEMED COMPLIANT FOR ALL ABANDONMENT REASONS

Effective date: 20260305

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20260305

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20260305

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20260305

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260305

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20260325